|
**Overview**: Calcium Total Ionized Panel**Introduction**: The Calcium Total Ionized Panel is a diagnostic tool designed to assess calcium levels using serum samples. In India, disorders of calcium metabolism (hyperparathyroidism, vitamin D deficiency, renal failure) affect millions, with hypocalcemia common in nutritional deficiencies (prevalence 20-50 percent in certain groups) and hypercalcemia in malignancy or hyperparathyroidism. Ionized calcium reflects physiologically active fraction, more accurate than total in acid-base disturbances or hypoalbuminemia. High morbidity from underdiagnosis in rural/low-SES populations, limited endocrinology/nephrology access, delayed treatment leading to tetany, arrhythmias, or bone disease. Per biochemistry practices aligned with ICMR and Endocrine Society of India guidelines, the test employs spectrophotometry for total and ionized calcium over 1-2 days with high sensitivity/specificity, valuable for precise evaluation in metabolic disorders. This diagnostic falls under bone/kidney screening and targets patients with symptoms of calcium imbalance, addressing accurate detection to guide supplementation or surgery. With elevated morbidity due to underdiagnosis, the test supports public health efforts by enabling precise identification and reducing complications. Its serum-based approach ensures reliable detection.**Other Names**: Ca Total Ion Pnl.**FDA Status**: FDA approved, CLIA certified for biochemistry, compliant with 2025 standards.**Historical Milestone**: Ionized calcium measurement advanced; in India, used in metabolic bone clinics.**Purpose**: The test assesses 2 parameters including total calcium and ionized calcium to guide calcium metabolism evaluation, detect hypo/hypercalcemia, inform treatment.**Test Parameters**: 1. Total Calcium, 2. Ionized Calcium.**Pretest Condition**: Fasting 10-12 hours recommended; patients should report muscle cramps, bone pain, fatigue, or kidney stones.**Specimen**: 3 mL serum in 1 SST, transported within specified times to maintain sample viability.**Sample Stability at Room Temperature**: 8 hours with proper handling to preserve analyte integrity, ensuring reliable test performance.**Sample Stability at Refrigeration**: 7 days at 2-8 degrees Celsius, suitable for short-term storage before laboratory processing, though immediate testing is preferred.**Sample Stability at Frozen**: 6 months at -20 degrees Celsius, allowing long-term storage for retesting, though freezing may affect some analytes.**Medical History**: Patients should provide details on symptoms, diet, sun exposure, family endocrine history, medications.**Consent**: Written informed consent is required, detailing the test's purpose, potential risks of untreated calcium disorders including tetany or arrhythmias, benefits of early detection, and minimal discomfort from venipuncture.**Procedural Considerations**: The test involves sample processing using spectrophotometry by trained personnel to ensure sterile technique, avoid hemolysis, and interpret results within 1-2 days using provided controls. Laboratories must maintain a controlled environment, adhere to quality assurance protocols, and store kits according to manufacturer specifications to ensure reliability.**Factors Affecting Result Accuracy**: Delays beyond stability periods, improper storage conditions, hemolysis, or acid-base imbalance can affect results. Correlation with clinical evaluation or additional testing is recommended to confirm findings.**Clinical Significance**: Abnormal levels indicate calcium disorder, necessitating specialist input. Normal may require follow-up in high-risk individuals.**Specialist Consultation**: Endocrinologists or nephrologists should be consulted for management.**Additional Supporting Tests**: PTH, vitamin D for confirmation.**Test Limitations**: Ionized measurement sensitive to pH; comprehensive approach required.**References**: Indian Journal of Endocrinology 2024, Calcium Metabolism Studies India 2023. |
